Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Nov 7, 2009; 15(41): 5141-5148
Published online Nov 7, 2009. doi: 10.3748/wjg.15.5141
Published online Nov 7, 2009. doi: 10.3748/wjg.15.5141
WHO 1999 | ATP III 2001 | IDF 2005 |
Diabetes or impaired fasting glycemia or impaired glucose tolerance or insulin resistance | Three or more of the following: Central obesity: waist circumference > 102 cm (male), > 88 cm (female) Hypertriglyceridemia: triglycerides > 150 mg/dL Low HDL cholesterol: < 40 mg/dL (male), < 50 mg/dL (female) Hypertension: blood pressure > 130/85 mmHg Fasting plasma glucose > 100 mg/dL | Increased waist circumference > 94 cm cm in men and > 80 cm in women plus any 2 of the following: Hypertriglyceridemia: triglycerides > 150 mg/dL Low HDL cholesterol: < 40 mg/dL (male), < 50 mg/dL (female) Hypertension: blood pressure > 130/85 mmHg Fasting plasma glucose > 100 mg/dL |
Plus 2 or more of the following: Obesity: BMI > 30 or waist-to-hip ratio > 0.9 (male) or 0.85 (female) Dyslipidemia: triglycerides > 150 mg/dL or HDL cholesterol < 35 mg/dL (male) or < 39 mg/dL (female) Hypertension: blood pressure > 140/90 mmHg Microalbuminuria: albumin excretion > 20 μg/min |
- Citation: Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009; 15(41): 5141-5148
- URL: https://www.wjgnet.com/1007-9327/full/v15/i41/5141.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.5141